SIRT3 is a Mitochondrial Tumor Suppressor and Genetic Loss Results in a Murine Model for ER/PR-Positive Mammary Tumors Connecting Metabolism and Carcinogenesis Mitochondrial Tumor Suppressor. Revision

Abstract

The incidence of human malignancies increases significantly with age, suggesting a mechanistic connection between aging (longevity) and carcinogenesis Breast malignancies that develop with increasing age very likely represent a spectrum of cancers arising from different types of hereditary and spontaneous tumors. Murine models for hereditary breast cancer in younger women have been established by altering the expression of BRCA genes. In contrast, there are no murine models for the spontaneous breast cancers that are more common in older women. The work supported by this DOD idea award has allows us to not only validate the first ER+ in vivo murine model for breast cancers but is has also allowed the discovery of several potential molecular targets that may potential be used for either chemoprevention or as anticancer agents.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 01, 2013
Accession Number
ADA604003

Entities

People

  • Michael R Freeman

Organizations

  • Vanderbilt University

Tags

DTIC Thesaurus Topics

  • Antineoplastic Agents
  • Breast Cancer
  • Cancer
  • Carcinoma
  • Cells
  • Chemistry
  • Data Mining
  • Data Sets
  • Databases
  • Diseases And Disorders
  • Drug Therapy
  • Information Science
  • Metabolism
  • Mitochondria
  • Neoplasms
  • Oncology
  • Therapy

Fields of Study

  • Biology

Readers

  • Breast cancer cell signaling and growth regulation.
  • Gender and Food Studies
  • Immunology

Technology Areas

  • Biotechnology